بدائل البحث:
significant based » significant cause (توسيع البحث), significant barrier (توسيع البحث), significant burden (توسيع البحث)
mean decrease » a decrease (توسيع البحث)
teer decrease » greater decrease (توسيع البحث)
based case » base case (توسيع البحث), based cancer (توسيع البحث)
significant based » significant cause (توسيع البحث), significant barrier (توسيع البحث), significant burden (توسيع البحث)
mean decrease » a decrease (توسيع البحث)
teer decrease » greater decrease (توسيع البحث)
based case » base case (توسيع البحث), based cancer (توسيع البحث)
-
81
-
82
-
83
-
84
The effect of HA digestion and HA replenishment alone or with CS on barrier function measured by TEER.
منشور في 2025"…In (B) and (C) each point represents a mean ± standard deviation. (B) Hyaluronidase treatment (n = 8) gradually increased TEER, this significantly differed from the untreated group (n = 8) and the PS treated group (n = 8) (p < 0,001). …"
-
85
-
86
-
87
Synaptopathy at IHC-SGN synapses decreases the peak of the CAP significantly, without changes to peak latency and width.
منشور في 2021"…Shaded regions correspond to the standard error of the mean and dashed lines correspond to the peaks of each CAP, labeled with the same colors as the CAPs. …"
-
88
-
89
The base case analysis.
منشور في 2025"…</p><p>Results</p><p>In the base-case scenario, adding benmelstobart and anlotinib to chemotherapy increased QALYs by 0.34 at an additional cost of $24,684.07, yielding an ICER of $71,559.84 per QALY. …"
-
90
-
91
Base-case results.
منشور في 2025"…One-way and probabilistic sensitivity analyses were conducted to estimate the robustness of the model results,</p><p>Results</p><p>In base-case analysis, compared with toripalimab plus chemotherapy and chemotherapy alone, ITH-testing directed therapy could bring additional 0.14 QALYs and 0.29 QALYs, with marginal costs of $3750.75 and $7778.18, resulting in the ICER of $27,353.27/QALY and $26,461.46/QALY, respectively, which lower than the Chinese willingness-to-pay (WTP) threshold. …"
-
92
-
93
Base-case results.
منشور في 2024"…The model time-frame was one-year. Base-case analysis and sensitivity analysis were performed. …"
-
94
Base-case analysis.
منشور في 2023"…The willingness-to-pay (WTP) threshold was set at US$50,000 per QALY gained. In the base-case analysis, HTLV-1 antenatal screening (US$76.85, 24.94766 QALYs, 24.94813 LYs, ICER; US$40,100 per QALY gained) was cost-effective compared with no screening (US$2.18, 24.94580 QALYs, 24.94807 LYs). …"
-
95
-
96
-
97
-
98
-
99
-
100